-

United States Architecture, Engineering, Construction (AEC) Firms Principals, Partners & Owners Survey Report 2021 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "2021 Principals, Partners & Owners Survey Report of U.S Architecture, Engineering, Construction (AEC) Firms" report has been added to ResearchAndMarkets.com's offering.

2021 Principals, Partners & Owners Survey Report of AEC Firms is a comprehensive study of owners and top managers of U.S. AEC firms. This eye-opening report covers ownership, stock appreciation, buy/sell agreements, non-compete agreements, voting rights, roles, responsibilities, perks, compensation, and more.

The 2021 Principals, Partners & Owners Survey Report has data on the following:

  • Principal compensation, benefits, and perks
  • Common issues and challenges related to running an AEC firm
  • Qualifications, job requirements, and demographics of principals, partners, & owners in the industry
  • Employment agreements, non-competes, and stock buyback provisions
  • How principals manage time and break down the work day

Key Features:

  • Compensation: The report has comparative data on salaries, bonuses, owner distributions, total compensation, and perks by firm type, region, size, growth rate, and firm profit, plus by the principal's title, the percentage of ownership, age, and gender.
  • Perks: What's normal and what's excessive in the area of "perks" for principals? Get statistics on every kind of perk-including vacations, cellular phones, country club memberships, tax preparation, and auto allowances.
  • Roles & Responsibilities: Data on how many hours principals typically work per week, their chargeability, time spent on different tasks, vacation taken (or not taken), and more. We also asked principals how they felt about their fellow owners and board of directors.

For the 2021 edition, principals from across the U.S. in the AEC industry responded to a questionnaire on the topics above. Their responses were then tabulated and analyzed.

For more information about this report visit https://www.researchandmarkets.com/r/2h9ctb

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Hexabromocyclododecane provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a v...

Commercial Gas Rice Cookers Market Report 2026: Revenues Set to Reach $2 Billion by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Commercial Gas Rice Cookers Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Commercial Gas Rice Cookers Market is experiencing significant growth, evolving from USD 1.28 billion in 2025 to an anticipated USD 2.00 billion by 2032, driven by a CAGR of 6.52%. This market research report provides a comprehensive analysis of the commercial gas rice cooker sector, highlighting key drivers like foodservice efficiency, industria...

Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth and promising potential in the treatment of malaria. Expected to increase from USD 386.40 million in 2025 to USD 608.26 million by 2032, supported by a steady CAGR of 6.69%, this market highlights the evolving landscape for modern antimalarial solutions. At the core of AC...
Back to Newsroom